LifeTech Scientific Corp
Company Profile
Business description
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
Contact
No. 22, Keji 12th Road South
14th Floor, LifeTech Scientific Building
High-tech Industrial Park
Nanshan District
Shenzhen518063
CHNT: +86 75586026250
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
1,240
Stocks News & Analysis
stocks
The best global tech stocks to buy
stocks
Earnings margins to improve for mining specialist
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,114.30 | 79.50 | -0.86% |
| CAC 40 | 8,264.43 | 41.72 | -0.50% |
| DAX 40 | 25,827.46 | 179.07 | -0.69% |
| Dow JONES (US) | 53,414.25 | 271.86 | -0.51% |
| FTSE 100 | 10,788.61 | 33.52 | -0.31% |
| HKSE | 25,317.18 | 95.94 | -0.38% |
| NASDAQ | 26,506.99 | 77.07 | -0.29% |
| Nikkei 225 | 65,269.33 | 1,130.52 | -1.70% |
| NZX 50 Index | 13,792.90 | 149.93 | -1.08% |
| S&P 500 | 7,718.60 | 29.11 | -0.38% |
| S&P/ASX 200 | 8,920.80 | 82.20 | -0.91% |
| SSE Composite Index | 3,940.55 | 7.85 | 0.20% |